Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26
Rhea-AI Summary
Privia Health (Nasdaq: PRVA) expects to release financial results for the fourth quarter and full year ended December 31, 2025 before market open on Thursday, February 26, 2026. The release is expected to be publicly available by 7:00 AM ET and on the company's investor relations website. Management will host a conference call and live webcast to discuss results and outlook beginning at 8:00 AM ET the same day; the webcast will be archived for on-demand replay. To join the live call, dial 888-596-4144 (or 646-968-2525 internationally) and use Conference ID 5704885.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, PRVA gained 1.53%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
PRVA gained 1.68% while close peers showed mixed moves: PINC, BTSG, and HQY were modestly positive, whereas WAY and PHR declined. No coordinated sector-wide pattern is evident from this data.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 06 | Q3 2025 earnings | Positive | -4.2% | Strong Q3 growth and raised FY25 guidance across key metrics. |
| Oct 07 | Earnings date notice | Neutral | -0.5% | Announcement of Q3 2025 results release and conference call timing. |
| Sep 23 | ACO acquisition | Positive | -0.6% | Cash acquisition of Evolent ACO business adding 120,000+ lives. |
| Aug 28 | MSSP performance | Positive | +5.6% | Reported $233.1M MSSP savings and raised 2025 EBITDA guidance. |
| Aug 07 | Q2 2025 earnings | Positive | -1.4% | Q2 growth and guidance raised despite moderated operating income. |
Recent history shows a tendency for PRVA to trade lower after fundamentally positive updates, with three negative reactions following strong earnings or strategic news and only one notably positive response.
Over the last five months, Privia Health has reported strong Q2 and Q3 2025 revenue growth, rising Adjusted EBITDA, and expanded value-based care lives, while maintaining a debt-free balance sheet. It also announced a cash-funded ACO acquisition from Evolent and highlighted $233.1M in 2024 MSSP savings and higher 2025 EBITDA guidance. Despite these fundamentally positive updates, share reactions often skewed negative, making today’s simple Q4 2025 reporting date notice a comparatively low-stakes milestone.
Market Pulse Summary
This announcement sets expectations for the Q4 and full-year 2025 earnings release and conference call, giving investors a clear timetable for updated financials and outlook. In recent quarters, PRVA has reported solid growth in revenue, Adjusted EBITDA, and value-based care lives, alongside acquisitions that expand its footprint. Investors may focus on how Q4 results and guidance reflect these prior initiatives and whether growth and liquidity trends continue.
AI-generated analysis. Not financial advice.
ARLINGTON, Va., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth-quarter and twelve-month periods ended December 31, 2025 before market open on Thursday, February 26, 2026.
The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company’s Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, February 26, to discuss the results and management’s outlook for future financial and operational performance.
You can visit ir.priviahealth.com/news-and-events/events-and-presentations to listen to the call via live webcast. The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call under the same link. To participate in the live conference call, dial 888-596-4144 (or 646-968-2525 for international callers) and provide Conference ID 5704885.
About Privia Health
Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 15 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 5.6+ million patients, and reward 5,200+ physicians and advanced practitioners for delivering high-value care.
Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com.
Contact
Robert Borchert
SVP, Investor & Corporate Communications
IR@priviahealth.com
817.783.4841
FAQ
When will Privia Health (PRVA) report Q4 and full-year 2025 results?
What time is the Privia Health (PRVA) earnings call on February 26, 2026?
Where can I find Privia Health (PRVA) Q4 2025 press release and webcast?
How do I dial into Privia Health's (PRVA) live conference call?
Will the Privia Health (PRVA) webcast be available after the call?
What periods are covered by Privia Health's (PRVA) February 26, 2026 results?
